Bruno Sainz, Jr. The Biomedical Research Network in Cancer (CIBERONC) Biography Publications Institution JoVE Articles Bruno Sainz, Jr. has not added a biography. If you are Bruno Sainz, Jr. and would like to personalize this page please email our Author Liaison for assistance. Publications Macrophages Direct Cancer Cells Through a LOXL2-mediated Metastatic Cascade in Pancreatic Ductal Adenocarcinoma Gut. Feb, 2023 | Pubmed ID: 35428659 Dysregulated Splicing Factor SF3B1 Unveils a Dual Therapeutic Vulnerability to Target Pancreatic Cancer Cells and Cancer Stem Cells with an Anti-splicing Drug Journal of Experimental & Clinical Cancer Research : CR. Dec, 2021 | Pubmed ID: 34857016 Correction: Earl Et Al. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. 2021, , 1612 Cancers. Jul, 2021 | Pubmed ID: 34359822 Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study Cancers. Apr, 2021 | Pubmed ID: 33916610 Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes Gastroenterology. Jul, 2021 | Pubmed ID: 33819482 Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals Negativity and a Longer Overall Survival Cancers. Mar, 2021 | Pubmed ID: 33807330 Exploiting Oxidative Phosphorylation to Promote the Stem and Immunoevasive Properties of Pancreatic Cancer Stem Cells Nature Communications. Oct, 2020 | Pubmed ID: 33067432 ISG15 and ISGylation is Required for Pancreatic Cancer Stem Cell Mitophagy and Metabolic Plasticity Nature Communications. May, 2020 | Pubmed ID: 32472071 Tumor-associated Macrophage-secreted 14-3-3ζ Signals Via AXL to Promote Pancreatic Cancer Chemoresistance Oncogene. Jul, 2019 | Pubmed ID: 30936462 Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 Cancer Research
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue (Video) | JoVE Jesús Frutos Díaz-Alejo*1,2,3,4, Simon April-Monn*5, Marina Cihova6, Verona Buocikova6, Jorge Villalón López1,3, Maria Urbanova6, Carmen G. Lechuga7, Miroslav Tomas6,8, Peter Dubovan6,8, Bárbara Luna Sánchez3, Sonia Camaño Páez3, Alfonso Sanjuanbenito2,9, Eduardo Lobo9, Estefanía Romio de la Heras10, Carmen Guerra2,7, Carolina de la Pinta11, Emma Barreto Melian1,2, Mercedes Rodríguez Garrote1,2, Alfredo Carrato1,2,4, Laura Ruiz-Cañas3,12,13, Bruno Sainz, Jr.2,3,12,13, Ana Torres3, Bozena Smolkova6, Julie Earl1,2,3 1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS), 2The Biomedical Research Network in Cancer (CIBERONC), 3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS), 4Faculty of Medicine, University of Alcalá de Henares, 5Institute of Tissue Medicine and Pathology, University of Bern, 6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, 7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), 8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University, 9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal, 10Department of Pathology, Hospital Universitario Ramón y Cajal, 11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, 12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM), 13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS JoVE 65229 Cancer Research